Immediate Impact

1 from Science/Nature 72 standout
Sub-graph 1 of 21

Citing Papers

Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease
2025 Standout
3 intermediate papers

Works of Jennifer Ackil being referenced

A phase II study of lorlatinib in patients (pts) with ALK-positive (ALK+) lung cancer with brain-only progression.
2020
Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLC
2019

Author Peers

Author Last Decade Papers Cites
Jennifer Ackil 209 158 100 5 235
Rossella Messina 201 161 51 6 232
Marta Román 124 115 65 7 290
Sarah Smalley 126 77 127 8 194
Masayoshi Miyawaki 223 177 43 7 256
Florian Malchers 218 190 78 7 296
Omar Hayatt 108 81 106 4 234
Wangjuh Chen 113 167 82 4 239
Mónica Garzón 145 103 110 6 253
Juan Antonio Barrera 105 158 129 7 294
Olen Stephens 114 126 42 7 226

All Works

Loading papers...

Rankless by CCL
2026